These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30863125)

  • 41. Erratum: Clinical outcome following DIAM implantation for symptomatic lumbar internal disk disruption: a 3-year retrospective analysis [Corrigendum].
    J Pain Res; 2017; 10():1931. PubMed ID: 28860847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
    Matsumoto K; Kanazawa N; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    J Infect Chemother; 2010 Jun; 16(3):193-9. PubMed ID: 20195882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erratum: Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum].
    Drug Healthc Patient Saf; 2018; 10():67-68. PubMed ID: 30038524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erratum: 10 kHz spinal cord stimulation: a retrospective analysis of real-world data from a community-based, interdisciplinary pain facility [Corrigendum].
    J Pain Res; 2019; 12():543-544. PubMed ID: 30787632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level.
    Sato M; Chida K; Suda T; Muramatsu H; Suzuki Y; Hashimoto H; Gemma H; Nakamura H
    J Infect Chemother; 2006 Aug; 12(4):185-9. PubMed ID: 16944256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teicoplanin pharmacokinetics in pediatric patients.
    Dufort G; Ventura C; Olivé T; Ortega JJ
    Pediatr Infect Dis J; 1996 Jun; 15(6):494-8. PubMed ID: 8783345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corrigendum.
    Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.
    Yamada T; Kubota T; Yonezawa M; Nishio H; Kanno S; Yano T; Kobayashi D; Egashira N; Takada H; Hara T; Masuda S
    Pediatr Infect Dis J; 2017 Apr; 36(4):398-400. PubMed ID: 27977550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
    Matthews PC; Chue AL; Wyllie D; Barnett A; Isinkaye T; Jefferies L; Lovering A; Scarborough M
    J Infect; 2014 Jan; 68(1):43-9. PubMed ID: 24012820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erratum: Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum].
    Neuropsychiatr Dis Treat; 2019; 15():655. PubMed ID: 30880990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erratum: Efficacy and effectiveness trials have different goals, use different tools, and generate different messages [Corrigendum].
    Pragmat Obs Res; 2016; 7():1. PubMed ID: 27801423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.
    Wi J; Noh H; Min KL; Yang S; Jin BH; Hahn J; Bae SK; Kim J; Park MS; Choi D; Chang MJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erratum: A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial [Corrigendum].
    Ther Clin Risk Manag; 2018; 14():1155. PubMed ID: 29983570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome.
    MacGowan A; White L; Reeves D; Harding I
    J Infect Chemother; 1996; 2(4):197-208. PubMed ID: 29681369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: A systematic review and meta-analysis.
    Hanai Y; Takahashi Y; Niwa T; Mayumi T; Hamada Y; Kimura T; Matsumoto K; Fujii S; Takesue Y
    J Clin Pharm Ther; 2021 Jun; 46(3):622-632. PubMed ID: 33547647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum: Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum].
    J Pain Res; 2018; 11():213. PubMed ID: 29406534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erratum: The impact of
    Pharmgenomics Pers Med; 2018; 11():167. PubMed ID: 30310303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria.
    de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G
    J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R; Paganini H; Gómez S; Casimir L; Stamboulian D
    Medicina (B Aires); 2002; 62 Suppl 2():48-51. PubMed ID: 12481489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.